Oura, a dominant player in the smart ring sector, recently unveiled its intention to purchase Counsel Health, an innovative AI-driven primary care enterprise, for a sum of $625 million. This significant acquisition comes on the heels of Oura's decision to indefinitely delay its anticipated $2.2 billion initial public offering, a move attributed to prevailing uncertainties within the IPO market. This strategic consolidation is poised to redefine Oura's service offerings, integrating advanced medical consultation capabilities directly into its ecosystem.
The integration of Counsel Health’s AI platform into the Oura application, which commenced in June, enables users to access personalized medical guidance and consult with licensed medical professionals seamlessly. This expanded partnership is set to enhance Oura’s capacity to deliver comprehensive healthcare solutions, spanning preventative, acute, and specialized chronic care. Facing increasing competition in the smart ring market, this acquisition underscores Oura's commitment to innovation and expansion beyond its core product, aiming to empower users with more accessible medical support.
Counsel Health, which secured $25 million in Series A funding a year prior from prominent investors like Andreessen Horowitz (a16z) and GV, had accumulated approximately $36 million in total funding. Following the acquisition, Counsel Health will maintain its operations, continuing to serve both existing and new enterprise clients. This will facilitate the broader dissemination of its AI-native care model to a wider audience, extending beyond Oura’s existing membership base. Muthu Alagappan, Counsel’s CEO, will transition to Oura as the chief clinical AI officer, bringing his team of 70 employees to contribute to Oura’s vision of a more connected and personalized healthcare future. The transaction is projected to finalize by the end of 2027. Oura also reported substantial financial growth, with a 153% year-over-year revenue increase to $533 million for the quarter ending September 30, and an impressive $1.75 billion in revenue for fiscal year 2026, marking a 92% annual growth. The company’s valuation previously reached $11 billion after a $900 million late-stage funding round in October 2025.
This strategic acquisition represents a bold step towards a future where technology and healthcare converge to offer more immediate, personalized, and proactive health management. By combining wearable technology with AI-driven medical expertise, companies like Oura and Counsel Health are paving the way for a healthier society, making advanced medical insights and care more readily available to individuals. It highlights the profound potential of technological innovation to foster well-being and elevate the standard of personal health management.
